Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 4:14 PM View:  | Woodhouse David J Chief Executive Officer Director | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 97,654 | -- | -- | (100%) 97.65K to 0 | |
| 08-Apr-24 4:16 PM View: | Rieflin William Jl Director | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 2,769,170 | -- | -- | (100%) 2.77M to 0 | |
| 08-Apr-24 4:14 PM View: | Viret Jean-Frederic Chief Financial Officer | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 3,038 | -- | -- | (100%) 3.04K to 0 | |
| 08-Apr-24 4:18 PM View: | Pierce Valerie L See Remarks | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 26,458 | -- | -- | (100%) 26.46K to 0 | |
| 08-Apr-24 8:02 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Acquisition (other) | 1,000 | -- | -- | < 1% 22.01M to 22.01M | |
| 08-Apr-24 8:04 PM View: | Column Group Gp, Lp 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition Duplicate | 6,949,600 | -- | -- | (100%) 6.95M to 1.0K | |
| 08-Apr-24 8:03 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 11,103,300 | -- | -- | (62%) 18.05M to 6.95M | |
| 08-Apr-24 8:05 PM View: | Tcg Opportunity III Gp, LLC 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 11,103,300 | -- | -- | (62%) 18.05M to 6.95M | |
| 08-Apr-24 4:12 PM View: | Hooper Suzanne Sawochka Director | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 7,000 | -- | -- | (100%) 7.0K to 0 | |
| 08-Apr-24 8:02 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 134,180 | -- | -- | (< 1%) 22.01M to 21.88M | |
| 08-Apr-24 8:04 PM View: | Column Group Gp, Lp 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition Duplicate | 3,690,480 | -- | -- | (17%) 21.74M to 18.05M | |
| 08-Apr-24 8:04 PM View: | Column Group Gp, Lp 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Acquisition (other) Duplicate | 1,000 | -- | -- | < 1% 21.74M to 21.74M | |
| 08-Apr-24 8:03 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 6,949,600 | -- | -- | (100%) 6.95M to 1.0K | |
| 08-Apr-24 8:05 PM View: | Tcg Opportunity III Gp, LLC 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition Duplicate | 6,949,600 | -- | -- | (100%) 6.95M to 1.0K | |
| 08-Apr-24 4:14 PM View: | Woodhouse David J Chief Executive Officer Director | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 23,993 | -- | -- | (20%) 121.65K to 97.65K | |
| 08-Apr-24 4:16 PM View: | Rieflin William Jl Director | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 5,172 | -- | -- | (< 1%) 2.77M to 2.77M | |
| 08-Apr-24 4:14 PM View: | Perlich Irene Principal Accounting Officer | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 6,284 | -- | -- | (100%) 6.28K to 0 | |
| 08-Apr-24 4:08 PM View: | Lieu Hsiao Chief Medical Officer | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition (change in control) | 19,349 | -- | -- | (100%) 19.35K to 0 | |
| 08-Apr-24 8:02 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 21,874,400 | -- | -- | (100%) 21.88M to 1.0K | |
| 08-Apr-24 8:04 PM View: | Column Group Gp, Lp 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 11,103,300 | -- | -- | (62%) 18.05M to 6.95M | |
| 08-Apr-24 8:03 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition | 3,690,480 | -- | -- | (17%) 21.74M to 18.05M | |
| 08-Apr-24 8:05 PM View: | Tcg Opportunity III Gp, LLC 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Disposition Duplicate | 3,690,480 | -- | -- | (17%) 21.74M to 18.05M | |
| 08-Apr-24 8:03 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Acquisition (other) Duplicate | 1,000 | -- | -- | < 1% 21.74M to 21.74M | |
| 08-Apr-24 8:05 PM View: | Tcg Opportunity III Gp, LLC 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 05-Apr-24 | Acquisition (other) Duplicate | 1,000 | -- | -- | < 1% 21.74M to 21.74M | |
| 18-Jan-24 6:01 PM View: | Woodhouse David J Chief Executive Officer Director | Ngm Biopharmaceuticals Inc (NGM) | 16-Jan-24 | Payment of Exercise | 13,032 | $1.34 | $17,462.90 | (6%) 224.85K to 211.82K | |
| 18-Jan-24 6:02 PM View: | Perlich Irene Principal Accounting Officer | Ngm Biopharmaceuticals Inc (NGM) | 16-Jan-24 | Payment of Exercise | 1,025 | $1.34 | $1,373.50 | (10%) 10.0K to 8.97K | |
| 18-Jan-24 6:03 PM View: | Lieu Hsiao EVP, Chief Medical Officer | Ngm Biopharmaceuticals Inc (NGM) | 16-Jan-24 | Payment of Exercise | 5,430 | $1.34 | $7,276.20 | (9%) 59.68K to 54.25K | |
| 18-Jan-24 6:02 PM View: | Pierce Valerie L SVP, GC & CCO | Ngm Biopharmaceuticals Inc (NGM) | 16-Jan-24 | Payment of Exercise | 5,021 | $1.34 | $6,728.14 | (8%) 60.4K to 55.37K | |
| 17-Nov-23 4:25 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 16-Nov-23 | Purchase | 1,460 | $0.62 | $906.81 | < 1% 22.0M to 22.0M | |
| 17-Nov-23 4:30 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 16-Nov-23 | Purchase Duplicate | 5,840 | $0.62 | $3,627.22 | < 1% 21.74M to 21.74M | |
| 17-Nov-23 4:25 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 16-Nov-23 | Purchase | 5,840 | $0.62 | $3,627.22 | < 1% 22.0M to 22.01M | |
| 17-Nov-23 4:28 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 16-Nov-23 | Purchase Duplicate | 5,840 | $0.62 | $3,627.22 | < 1% 21.74M to 21.74M | |
| 17-Nov-23 4:33 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 16-Nov-23 | Purchase Duplicate | 5,840 | $0.62 | $3,627.22 | < 1% 21.74M to 21.74M | |
| 17-Nov-23 4:28 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 15-Nov-23 | Private Purchase Duplicate | 16,791 | $0.71 | $11,879.60 | < 1% 21.72M to 21.74M | |
| 17-Nov-23 4:25 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 15-Nov-23 | Private Purchase | 2,720 | $0.71 | $1,918.69 | < 1% 21.98M to 21.98M | |
| 17-Nov-23 4:33 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 15-Nov-23 | Private Purchase Duplicate | 16,791 | $0.71 | $11,879.60 | < 1% 21.72M to 21.74M | |
| 17-Nov-23 4:25 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 15-Nov-23 | Purchase | 16,791 | $0.71 | $11,879.60 | < 1% 21.98M to 22.0M | |
| 17-Nov-23 4:30 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 15-Nov-23 | Private Purchase Duplicate | 16,791 | $0.71 | $11,879.60 | < 1% 21.72M to 21.74M | |
| 06-Mar-23 5:09 PM View: | Woodhouse David J Chief Executive Officer Director | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 127,200 | -- | -- | 130% 97.65K to 224.85K | |
| 06-Mar-23 5:05 PM View: | Chen Jin-Long Chief Scientific Officer Director | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 64,000 | -- | -- | 7% 908.89K to 972.89K | |
| 06-Mar-23 5:08 PM View: | Lieu Hsiao SVP, Chief Medical Officer | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 53,000 | -- | -- | 2035% 2.6K to 55.6K | |
| 06-Mar-23 5:03 PM View: | Pierce Valerie L SVP, GC & CCO | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 49,000 | -- | -- | 735% 6.67K to 55.67K | |
| 06-Mar-23 5:12 PM View: | Nolan Mangini Siobhan President and CFO | Ngm Biopharmaceuticals Inc (NGM) | 02-Mar-23 | Grant | 76,000 | -- | -- | 100% 0 to 76.0K | |
| 01-Feb-23 4:26 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 31-Jan-23 | Purchase | 176,730 | $5.00 | $883,403.00 | < 1% 21.81M to 21.98M | |
| 01-Feb-23 4:29 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 31-Jan-23 | Purchase Duplicate | 176,730 | $5.00 | $883,403.00 | < 1% 21.54M to 21.72M | |
| 01-Feb-23 4:50 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 31-Jan-23 | Purchase Duplicate | 176,730 | $5.00 | $883,403.00 | < 1% 21.54M to 21.72M | |
| 01-Feb-23 4:31 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 31-Jan-23 | Purchase Duplicate | 176,730 | $5.00 | $883,403.00 | < 1% 21.54M to 21.72M | |
| 01-Feb-23 4:50 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 30-Jan-23 | Private Purchase Duplicate | 7,542 | $5.00 | $37,707.00 | < 1% 21.54M to 21.54M | |
| 01-Feb-23 4:31 PM View: | Column Group L P Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 30-Jan-23 | Private Purchase Duplicate | 7,542 | $5.00 | $37,707.00 | < 1% 21.54M to 21.54M | |
| 01-Feb-23 4:26 PM View: | Goeddel David V Director 10% Owner | Ngm Biopharmaceuticals Inc (NGM) | 30-Jan-23 | Private Purchase | 7,542 | $5.00 | $37,707.00 | < 1% 21.8M to 21.81M |
